[Role and mechanism of methyltransferase-like 3 in promoting macrophage NLRP3 inflammatory responses in medication-related osteonecrosis of the jaw].
Researchers used single-cell analysis to show that METTL3, an epigenetic modifier, promotes inflammatory responses in macrophages via NLRP3 activation in bisphosphonate-related jaw osteonecrosis, suggesting it as a potential therapeutic target.
A plain-English summary of the study's own findings — we don't add our own claims or interpretation. Read the full paper for the complete methods and results, and apply your own clinical judgement.
Read the full study at the sourceRelated CPD from Vital Pulp
Managing the Pregnant Dental Patient
Confident, evidence-based dental care from the first trimester to the postpartum period
The Recall — the month's most significant new dental research, summarised. Free.
Browse The Recall